Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
bioAffinity Technologies, Inc.
organization9 mentionslast seen Oct 29, 2026
Biotechnology company developing noninvasive healthcare solutions for early detection and monitoring of lung disease.
Relationships 12
- bioAffinity Technologies, Inc.developsCyPath Lung99% confidence9 sources
- bioAffinity Technologies, Inc.ownsPrecision Pathology Laboratory Services99% confidence9 sources
- bioAffinity Technologies, Inc.employsMaria Zannes99% confidence9 sources
- bioAffinity Technologies, Inc.partners withAvMEDICAL99% confidence2 sources
- bioAffinity Technologies, Inc.employsGordon Downie99% confidence2 sources
- bioAffinity Technologies, Inc.employsGordon H. Downie98% confidence1 source
- bioAffinity Technologies, Inc.employsWilliam Bauta96% confidence1 source
- bioAffinity Technologies, Inc.authoredDetection of Early-Stage Lung Cancer in Sputum Using Automated Flow Cytometry and Machine Learning93% confidence1 source
- Hong Kong Patent No. HK40048460assigned tobioAffinity Technologies, Inc.90% confidence1 source
- bioAffinity Technologies, Inc.developssputum-based tests for lung inflammation88% confidence1 source
- bioAffinity Technologies, Inc.partners withVeteran-Owned AvMEDICAL85% confidence1 source
- bioAffinity Technologies, Inc.developsasthma and COPD inflammatory test80% confidence1 source
Relationship
bioAffinity Technologies, Inc.developsCyPath Lung
99% confidence9 supporting mentions
Either name opens that entity’s relationships.
Sources 9
- filingSEC EDGAROct 29, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company addressing the need for early lung cancer detection with its noninvasive CyPath ® Lung test
- filingSEC EDGAROct 15, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease
- filingSEC EDGAROct 13, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung by bioAffinity Technologies is a noninvasive test
- filingSEC EDGAROct 9, 2026bioAffinity Technologies, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc. a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease
- filingSEC EDGAROct 8, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer
- filingSEC EDGAROct 6, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease, today announced that sales of its CyPath® Lung test
- filingSEC EDGARSep 30, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc. , a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease
- filingSEC EDGARSep 22, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies, Inc., a biotechnology company developing noninvasive healthcare solutions
- filingSEC EDGARSep 17, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
bioAffinity Technologies is a biotechnology company developing noninvasive healthcare solutions